EGR1/2 Inhibits Papillary Thyroid Carcinoma Cell Growth by Suppressing the Expression of PTEN and BAX

Bhattacharyya S, Fang F, Tourtellotte W, Varga J (2013) Egr-1: new conductor for the tissue repair orchestra directs harmony (regeneration) or cacophony (fibrosis). J Pathol 229:286–297. https://doi.org/10.1002/path.4131

Cabanillas ME, McFadden DG, Durante C (2016) Thyroid cancer. Lancet 388:2783–2795. https://doi.org/10.1016/S0140-6736(16)30172-6

Cerami E et al (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2:401–404. https://doi.org/10.1158/2159-8290.CD-12-0095

Chen DG et al (2017) Inhibition of EGR1 inhibits glioma proliferation by targeting CCND1 promoter. J Exp Clin Cancer Res 36:186. https://doi.org/10.1186/s13046-017-0656-4

Cui J, Placzek WJ (2018) Post-transcriptional regulation of anti-apoptotic BCL2 family members. Int J Mol Sci. https://doi.org/10.3390/ijms19010308

Gao J et al (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6:1. https://doi.org/10.1126/scisignal.2004088

Gomez-Martin D, Diaz-Zamudio M, Galindo-Campos M, Alcocer-Varela J (2010) Early growth response transcription factors and the modulation of immune response: implications towards autoimmunity. Autoimmun Rev 9:454–458. https://doi.org/10.1016/j.autrev.2009.12.006

Grewal RK, Ho A, Schoder H (2016) Novel approaches to thyroid cancer treatment and response assessment. Semin Nucl Med 46:109–118. https://doi.org/10.1053/j.semnuclmed.2015.10.010

Hopkins BD, Hodakoski C, Barrows D, Mense SM, Parsons RE (2014) PTEN function: the long and the short of it. Trends Biochem Sci 39:183–190. https://doi.org/10.1016/j.tibs.2014.02.006

Kang HS, Ock J, Lee HJ, Lee YJ, Kwon BM, Hong SH (2013) Early growth response protein 1 upregulation and nuclear translocation by 2’-benzoyloxycinnamaldehyde induces prostate cancer cell death. Cancer Lett 329:217–227. https://doi.org/10.1016/j.canlet.2012.11.006

Kim J et al (2014) EGR1-dependent PTEN upregulation by 2-benzoyloxycinnamaldehyde attenuates cell invasion and EMT in colon cancer. Cancer Lett 349:35–44. https://doi.org/10.1016/j.canlet.2014.03.025

Kouniavsky G, Zeiger MA (2010) Thyroid tumorigenesis and molecular markers in thyroid cancer. Curr Opin Oncol 22:23–29. https://doi.org/10.1097/CCO.0b013e328333846f

Lalier L, Cartron PF, Juin P, Nedelkina S, Manon S, Bechinger B, Vallette FM (2007) Bax activation and mitochondrial insertion during apoptosis. Apoptosis 12:887–896. https://doi.org/10.1007/s10495-007-0749-1

Lin HY, Glinsky GV, Mousa SA, Davis PJ (2015) Thyroid hormone and anti-apoptosis in tumor cells. Oncotarget 6:14735–14743. https://doi.org/10.18632/oncotarget.4023

Liu D, Yang C, Bojdani E, Murugan AK, Xing M (2013) Identification of RASAL1 as a major tumor suppressor gene in thyroid cancer. J Natl Cancer Inst 105:1617–1627. https://doi.org/10.1093/jnci/djt249

LiVolsi VA (2011) Papillary thyroid carcinoma: an update. Mod Pathol 24(Suppl 2):S1-9. https://doi.org/10.1038/modpathol.2010.129

Lu L et al (2018) Egr2 enhances insulin resistance via JAK2/STAT3/SOCS-1 pathway in HepG2 cells treated with palmitate. Gen Comp Endocrinol 260:25–31. https://doi.org/10.1016/j.ygcen.2017.08.023

Narayanan S, Colevas AD (2016) Current standards in treatment of radioiodine refractory thyroid cancer. Curr Treat Options Oncol 17:30. https://doi.org/10.1007/s11864-016-0404-6

Novosel I, Bulimbasic S, Ramljak V, Matkovic B, Dosen D, Separovic V (2006) p53, bcl-2 and Ki-67 in the diagnosis of insular thyroid gland cancer. Case report with a review of literature. Lijec Vjesn 128:264–267

Osamura R, Grossman A, Korbonits M, Kovacs K, Lopes M, Matsuno A, Trouillas J (2017) WHO classification of tumours of endocrine organs. IARC Lyon, France

Petersohn D, Thiel G (1996) Role of zinc-finger proteins Sp1 and zif268/egr-1 in transcriptional regulation of the human synaptobrevin II gene. Eur J Biochem 239:827–834. https://doi.org/10.1111/j.1432-1033.1996.0827u.x

Roman BR, Morris LG, Davies L (2017) The thyroid cancer epidemic, 2017 perspective. Curr Opin Endocrinol Diabetes Obes 24:332–336. https://doi.org/10.1097/MED.0000000000000359

Santino P, Martignani E, Miretti S, Baratta M, Accornero P (2017) Mechanisms of modulation of the Egr gene family in mammary epithelial cells of different species. Gen Comp Endocrinol 247:87–96. https://doi.org/10.1016/j.ygcen.2017.01.020

Sherman SI (2003) Thyroid carcinoma. Lancet 361:501–511. https://doi.org/10.1016/s0140-6736(03)12488-9

Song MS, Salmena L, Pandolfi PP (2012) The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 13:283–296. https://doi.org/10.1038/nrm3330

Sukhatme VP (1991) The Egr family of nuclear signal transducers. Am J Kidney Dis 17:615–618. https://doi.org/10.1016/s0272-6386(12)80333-7

Sun Z et al (2019) EGR1 recruits TET1 to shape the brain methylome during development and upon neuronal activity. Nat Commun 10:3892. https://doi.org/10.1038/s41467-019-11905-3

Unoki M, Nakamura Y (2003) EGR2 induces apoptosis in various cancer cell lines by direct transactivation of BNIP3L and BAK. Oncogene 22:2172–2185. https://doi.org/10.1038/sj.onc.1206222

Wang Y, Chen Z (2020) Mutation detection and molecular targeted tumor therapies. STEMedicine 1:e11. https://doi.org/10.37175/stemedicine.v1i1.11

Worby CA, Dixon JE (2014) Pten. Annu Rev Biochem 83:641–669. https://doi.org/10.1146/annurev-biochem-082411-113907

Xing M (2013) Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer 13:184–199. https://doi.org/10.1038/nrc3431

Xing M (2019) Genetic-guided risk assessment and management of thyroid cancer. Endocrinol Metab Clin N Am 48:109–124. https://doi.org/10.1016/j.ecl.2018.11.007

Yang Y et al (2019) EGR1 interacts with DNMT3L to inhibit the transcription of miR-195 and plays an anti-apoptotic role in the development of gastric cancer. J Cell Mol Med. https://doi.org/10.1111/jcmm.14597

Young E et al (2017) EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia. Leukemia 31:1547–1554. https://doi.org/10.1038/leu.2016.359

Zeng XR, Sun Y, Wenger L, Cheung HS (2005) Basic calcium phosphate crystal-induced Egr-1 expression stimulates mitogenesis in human fibroblasts. Biochem Biophys Res Commun 330:658–664. https://doi.org/10.1016/j.bbrc.2005.03.036